CAMP4 Therapeutics Corporation (CAMP) vs Galectin Therapeutics Inc. (GALT)
A side-by-side comparison of CAMP4 Therapeutics Corporation and Galectin Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CAMP
CAMP4 Therapeutics Corporation
$3.86HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
GALT
Galectin Therapeutics Inc.
$3.67HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
Total return — CAMP vs GALT
growth of $100 · dividends reinvested · last 2yCAMP -62.6% (-38.8%/yr)GALT +37.1% (+17.1%/yr)GALT compounded faster over this window
CAMP GALT
CAMP vs GALT: by the numbers
- •CAMP is the larger company ($242M vs $242M market cap).
- •Both run net losses; GALT's is the smaller (0.00% vs -2543.74% net margin).
Metrics side by side
Valuation
| Metric | CAMP | GALT |
|---|---|---|
| P/S ratio | 57.45 | N/A |
Profitability
| Metric | CAMP | GALT |
|---|---|---|
| Gross margin | 53.14% | 0.00% |
| Operating margin | -1488.31% | 0.00% |
| Net margin | -2543.74% | 0.00% |
| ROIC | -69.76% | -1718.59% |
Growth (annualized)
| Metric | CAMP | GALT |
|---|---|---|
| Revenue CAGR (5Y) | -57.68% | N/A |
| Total return CAGR (5Y) | N/A | 0.60% |
Go deeper
Dig into the metrics
CAMP4 Therapeutics ROEGalectin Therapeutics ROECAMP4 Therapeutics operating marginGalectin Therapeutics operating marginCAMP4 Therapeutics revenue growthGalectin Therapeutics revenue growthCAMP4 Therapeutics free cash flowGalectin Therapeutics free cash flow
CAMP4 Therapeutics & Galectin Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.